Fig. 2From: Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?Overall Survival Curves Based on Validation Datasets (KEYNOTE-001 Melanoma Patients). Left panel shows the survival curves with 10% cut-off and the right panel shows survival curves with two cutoffs of 10 and 30% tumor reductionBack to article page